Endocannabinoids in the intact retina: 3H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide

Visual Neuroscience

Volumn 22, Issue 6, 2005, Pages 693-705

  Glaser, Sherrye T ^a,c   Deutsch, Dale G ^a   Studholme, Keith M ^b   Zimov, Sarah ^b   Yazulla, Stephen ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b Stony Brook University   (United States)

^c BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

Anandamide; Cannabinoid; Fatty acid amide hydrolase; Goldfish; Retina; Uptake

Indexed keywords

ANANDAMIDE; ANTIGEN; ENDOCANNABINOID; FATTY ACID AMIDASE; METHYLARACHIDONYLFLUOROPHOSPHONATE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; PEPTIDE; PHOSPHONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ADSORPTION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN; ELECTROPHYSIOLOGY; ENZYME ACTIVITY; GOLDFISH; HYDROLYSIS; IC 50; IMMUNOBLOTTING; IMMUNOREACTIVITY; IN VITRO STUDY; MUELLER CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA; RETINA AMACRINE CELL; RETINA CONE; RETINA GANGLION CELL; TEMPERATURE;

AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; AUTORADIOGRAPHY; BLOTTING, WESTERN; CONES (RETINA); ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENDOCANNABINOIDS; GOLDFISH; HYDROLYSIS; IMMUNOHISTOCHEMISTRY; POLYUNSATURATED ALKAMIDES; RETINA; SILVER STAINING;

EID: 32544447756     PISSN: 09525238     EISSN: 14698714     Source Type: Journal    
DOI: 10.1017/S0952523805226020     Document Type: Article

References (83)

1. ALGER, B.E. (2002). Retrograde signaling in the regulation of synaptic transmission: Focus on endocannabinoids. Progress in Neurobiology 68, 247-286.
2. AMERI, A. (1999). The effects of cannabinoids on the brain. Progress in Neurobiology 58, 315-348.
3. BELTRAMO, M., STELLA, N., CALIGNANO, A., LIN, S.Y., MAKRIYANNIS, A. & PIOMELLI, D. (1997). Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 277, 1094-1097.
4. BISOGNO, T., DELTON-VANDENBROUCKE, I., MILONE, A., LAGARDE, M. & DI MARZO, V. (1999). Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina. Archives of Biochemistry and Biophysics 370, 300-307.
5. BISOGNO, T., MELCK, D., BOBROV, M.Y., GRETSKAYA, N.M., BEZUGLOV, V.V., DE PETROCELLIS, L. & DI MARZO, V. (2000). N-acyl-dopamines: Novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. Biochemical Journal 351, 817-824.
6. BUCKLEY, N.E., HANSSON, S., HARTA, G. & MEZEY, É. (1998). Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat. Neuroscience 82, 1131-1149.
7. CONSROE, P., MUSTY, R., REIN, J., TILLERY, W. & PERTWEE, R.G. (1997). The perceived effects of smoked cannabis on patients with multiple sclerosis. European Neurology 38, 44-48.
8. CRAVATT, B.F., DEMAREST, K., PATRICELLI, M.P., BRACEY, M.H., GIANG, D.K., MARTIN, B.R. & LICHTMAN, A.H. (2001). Supersensitivity to anandamide and enhanced cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proceedings of the National Academy of Sciences of the U.S.A. 98, 9371-9376.
9. DAWSON, W.W., JIMENEZ-ANTILLON, C.F., PEREZ, J.M. & ZESKIND, J.A. (1977). Marijuana and vision - after ten years' use in Costa Rica. Investigative Ophthalmology and Visual Science 16, 689-699.
10. DAY, T.A., RAKHSHAN, F., DEUTSCH, D.G. & BARKER, E.L. (2001). Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide. Molecular Pharmacology 59, 1369-1375.
11. DE PETROCELLIS, L., BISOGNO, T., DAVIS, J.B., PERTWEE, R.G. & DI MARZO, V. (2000). Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: Inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Letters 483, 52-56.
12. DE PETROCELLIS, L., MELCK, D., UEDA, N., MAURELLI, S., KURAHASHI, T., YAMAMOTO, S., MARINO, G. & DI MARZO, V. (1997). Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase. Biochemical and Biophysical Research Communications 231, 82-88.
13. DESARNAUD, F., CADAS, H. & PIOMELLI, D. (1995). Anandamide amino-hydrolase activity in rat brain microsomes. Identification and partial characterization. Journal of Biological Chemistry 270, 6030-6035.
14. DEUTSCH, D.G. & CHIN, S.A. (1993). Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochemical Pharmacology 46, 791-796.
15. DEUTSCH, D.G., GLASER, S.T., HOWELL, J.M., KUNZ, J.S., PUFFENBARGER, R.A., HILLARD, C.J. & ABUMRAD, N. (2001). The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase. Journal of Biological Chemistry 276, 6967-6973.
16. DEUTSCH, D.G., OMEIR, R., ARREAZA, G., SALEHANI, D., PRESTWICH, G.D., HUANG, Z. & HOWLETT, A.C. (1997). Methyl arachidonyl fluorophosphonate: A potent irreversible inhibitor of anandamide amidase. Biochemical Pharmacology 53, 255-260.
17. DEUTSCH, D.G., UEDA, N. & YAMAMOTO, S. (2002). The fatty acid amide hydrolase (FAAH). Prostaglandins Leukotrienes and Essential Fatty Acids 66, 201-210.
18. DEVANE, W.A., HANUS, L., BREUER, A., PERTWEE, R.G., STEVENSON, L.S., GRIFFIN, G., GIBSON, D., MANDELBAUM, A., ETINGER, A. & MECHOULAM, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
19. DIANA, M.A. & MARTY, A. (2004). Endocannabinoid-mediated short-term synaptic plasticity: Depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). British Journal of Pharmacology 142, 9-19.
20. DI MARZO, V., DEPETROCELLIS, L., FEZZA, F., LIGRESTI, A. & BISOGNO, T. (2002). Anandamide receptors. Prostaglandins Leukotrienes and Essential Fatty Acids 66, 377-391.
21. DINH, T.P., CARPENTER, D., LESLIE, F.M., FREUND, T.F., KATONA, I., SENSI, S.L., KATHURIA, S. & PIOMELLI, D. (2002). Brain monoglyceride lipase participating in endocannabinoid inactivation. Proceedings of the National Academy of Sciences of the U.S.A. 99, 10819-10824.
22. EGERTOVÁ, M., GIANG, D.K., CRAVATT, B.F. & ELPHICK, M.R. (1998). A new perspective on cannabinoid signaling: Complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proceedings of the Royal Society B (London) 265, 2081-2085.
23. ELPHICK, M.R., SATOU, Y. & SATOH, N. (2003). The invertebrate ancestry of endocannabinoid signaling: An orthologue of vertebrate cannabinoid receptors in the urochordate Ciona intestinalis. Gene 302, 95-101.
24. FAN, S.F. & YAZULLA, S. (2003). Biphasic modulation of voltage-dependent currents of retinal cones by cannabinoid CB1 agonist, WIN 55212-2. Visual Neuroscience 20, 177-188.
25. FAN, S.F. & YAZULLA, S. (2004). Inhibitory interaction of cannabinoid CB1 receptor and dopamine D2 receptor agonists on voltage-gated currents of goldfish cones. Visual Neuroscience 21, 69-79.
26. K(V)) by activation of cannabinoid CB1 and dopamine D1 receptors in ON bipolar cells of goldfish retina. Visual Neuroscience 22, 55-63.
27. FEGLEY, D., GAETANI, S., DURANTI, A., TONTINI, A., MOR, M., TARZIA, G. & PIOMELLI, D. (2004a). Characterization of the fatty-acid amide hydrolase inhibitor URB597: Effects on anandamide and oleoylethanolamide deactivation. Journal of Pharmacology and Experimental Therapeutics 313, 352-358.
28. FEGLEY, D., KATHURIA, S., MERCIER, R., LI, C., GOUTOPOULOS, A., MAKRIYANNIS, A. & PIOMELLI, D. (2004b). Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. Proceedings of the National Academy of Sciences of the U.S.A. 101, 8756-8761.
29. FRIDE, E. (2002). Endocannabinoids in the central nervous system - An overview. Prostaglandins Leukotrienes and Essential Fatty Acids 66, 221-233.
30. FOWLER, C.J. (2004). Metabolism of the endocannabinoids Anandamide and 2-Arachidonoyl glycerol. A review, with emphasis on the pharmacology of fatty acid amide hydrolase, a possible target for the treatment of neurodegenerative diseases and pain. Current Medicinal Chemistry 4, 161-174.
31. GIANG, D.K. & CRAVATT, B.F. (1997). Molecular characterization of human and mouse fatty acid amide hydrolases. Proceedings of the National Academy of Sciences of the U.S.A. 94, 2238-2242.
32. GIUFFRIDA, A., BELTRAMO, M. & PIOMELLI, D. (2001). Mechanisms of endocannabinoid inactivation: Biochemistry and pharmacology. Journal of Pharmacology and Experimental Therapeutics 298, 7-14.
33. GLASER, S.T., ABUMRAD, N.A., FATADE, F., KACZOCHA, M., STUDHOLME, K.M. & DEUTSCH, D.G. (2003). Evidence against the presence of an anandamide transporter. Proceedings of the National Academy of Sciences of the U.S.A. 100, 4269-4274.
34. GULYAS, A.I., CRAVATT, B.F., BRACEY, M.H., DINH, T.P., PIOMELLI, D., BOSCIA, F. & FREUND, T.F. (2004). Segregation of two endocannabinoid- hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. European Journal of Neuroscience 20, 441-458.
35. HANUS, L., ABU-LAFI, S., FRIDE, E., BREUER, A., VOGEL, Z., SHALEV, D.E., KUSTANOVICH, I. & MECHOULAM, R. (2001). 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proceedings of the National Academy of Sciences of the U.S.A. 98, 3662-3665.
36. HERKENHAM, M., LYNN, A.B., ROSS JOHNSON, M.R., MELVIN, L.S., DE COSTA, B.R. & RICE, K.C. (1991). Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. Journal of Neuroscience 11, 563-583.
37. HILLARD, C.J., EDGEMOND, W.S., JARRAHIAN, A. & CAMPBELL, W.B. (1997). Accumulation of N-Arachidonoylethanolamine (Anandamide) into cerebellar granule cells occurs via facilitated diffusion. Journal of Neurochemistry 69, 631-638.
38. HILLARD, C.J. & JARRAHIAN, A. (2000). The movement of N-arachidonoylethanolamine (anandamide) across cellular membranes. Chemistry and Physics of Lipids 108, 123-134.
39. HILLARD, C.J., WILKISON, D.M., EDGEMOND, W.S. & CAMPBELL, W.B. (1995). Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain. Biochimica et Biophysica Acta 1257, 249-256.
40. JARRAHIAN, A., MANNA, S., EDGEMOND, W.S., CAMPBELL, W.B. & HILLARD, C.J. (2000). Structure-activity relationships among N-arachidonylethanolamine (anandamide) head group analogues for the anandamide transporter. Journal of Neurochemistry 74, 2597-2606.
41. JU, W.K. & NEUFELD, A.H. (2002). Cellular localization of cyclooxygenase-1 and cyclooxygenase-2 in the normal mouse, rat, and human retina. Journal of Comparative Neurology 452, 392-399.
42. KATAYAMA, K., UEDA, N., KURAHASHI, Y., SUZUKI, H., YAMAMOTO, S. & KATO, I. (1997). Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine. Biochimica et Biophysica Acta 1347, 212-218.
43. KATHURIA, S., GAETANI, S., FEGLEY, D., VALINO, F., DURANTI, A., TONTINI, A., MOR, M., TARZIA, G., LA RANA, G., CALIGNANO, A., GIUSTINO, A., TATTOLI, M., CUOMO, V. & PIOMELLI, D. (2003). Modulation of anxiety through blockade of anandamide hydrolysis. Nature Medicine 9, 76-81.
44. KIPLINGER, G.F., MANNO, J.E., RODDA, B.E. & FORNEY, R.B. (1971). Dose-response analysis of the effects of tetrahydrocannabinol in man. Clinical Pharmacology and Therapeutics 12, 650-657.
45. KLOOSTER, J., STUDHOLME, K.M. & YAZULLA, S. (2001). Localization of the AMPA subunit GluR2 in the outer plexiform layer of goldfish retina. Journal of Comparative Neurology 441, 155-167.
46. LEUNG, D., HARDOUIN, C., BOGER, D.L. & CRAVATT, B.F. (2003). Discovering potent and selective reversible inhibitors of enzymes in complex proteomes. Nature Biotechnology 6, 687-691.
47. LICHTMAN, A.H., HAWKINS, E.G., GRIFFIN, G. & CRAVATT, B.F. (2002). Pharmacological activity of fatty acids is regulated, but not mediated, by fatty acid amide hydrolase in vivo. Journal of Pharmacology and Experimental Therapeutics 302, 73-79.
48. LINSER, P.J., SMITH, K. & ANGELIDES, K. (1985). A comparative analysis of glial and neuronal markers in the retina of fish: Variable character of horizontal cells. Journal of Comparative Neurology 237, 264-272.
49. 2+-independent phospholipase A2 by methylarachidonyl fluorophosphonate. Biochimica et Biophysica Acta 1302, 55-60.
50. LÓPEZ-RODRÍGUEZ, M.L., VISO, A., ORTEGA-GUTIÉRREZ, S., FOWLER, C.J., TIGER, G., DELAGO, E., FERNÁNDEZ-RUIZ, J. & RAMOS, J.A. (2003). Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors. European Journal of Medical Chemistry 38, 403-412.
51. MAEJIMA, T., HASHIMOTO, K., YOSHIDA, T., AIBA, A. & KANO, M. (2001). Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 31, 463-475.
52. MATSUDA, S., KANEMITSU, N., NAKAMURA, A., MIMURA, Y., UEDA, N., KURAHASHI, Y. & YAMAMOTO, S. (1997). Metabolism of anandamide, an endogenous cannabinoid receptor ligand, in porcine ocular tissues. Experimental Eye Research 64, 707-711.
53. MCALLISTER, S.D. & GLASS, M. (2002). CB1 and CB2 receptor-mediated signalling: A focus on endocannabinoids. Prostaglandins Leukotrienes and Essential Fatty Acids 66, 161-171.
54. MECHOULAM, R., BEN-SHABAT, S., HANUS, L., LIGUMDKY, M., KAMINSKI, N.B., SHATZ, A.R., GOPHER, A., ALMOG, S., MARTIN, B.R. & COMPTON, D.R. (1995). Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochemical Pharmacology 50, 83-90.
55. MELIS, M., PERRA, S., MUNTONI, A.L., PILLOLLA, G., LUTZ, B., MARSICANO, G., DI, M.V, GESSA, G.L. & PISTIS, M. (2004). Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons. Journal of Neuroscience 24, 10707-10715.
56. MILLER, R.F. & DOWLING, J.E. (1970). Intracellular responses of the Müller (glial) cells of the mudpuppy retina: Their relation to the b-wave of the electroretinogram. Journal of Neurophysiology 33, 323-341.
57. OHNO-SHOSAKU, T., SHOSAKU, J., TSUBOKAWA, H. & KANO, M. (2002). Cooperative endocannabinoid production by neuronal depolarization and group I metabotropic glutamate receptor activation. European Journal of Neuroscience 15, 953-961.
58. ORTAR, G., LIGRESTI, A., DEPETROCELLIS, L., MORERA, E. & DIMARZO, V. (2003). Novel selective and metabolically stable inhibitors of anandamide cellular uptake. Biochemical Pharmacology 65, 1473-1481.
59. PERTWEE, R.G. & ROSS, R.A. (2002). Cannabinoid receptors and their ligands. Prostaglandins Leukotrienes and Essential Fatty Acids 66, 101-121.
60. PIOMELLI, D., BELTRAMO, M., GLASNAPP, S., LIN, S.Y., GOUTOPOULOS, A., XIE, X.Q. & MAKRIYANNIS, A. (1999). Structural determinants for recognition and translocation by the anandamide transporter. Proceedings of the National Academy of Sciences of the U.S.A. 96, 5802-5807.
61. 1 mRNA is highly expressed in the rat ciliary body: Implications for the antiglaucoma properties of marihuana. Molecular Brain Research 58, 240-245.
62. QUISTAD, G.B., SPARKS, S.E., SEGALL, Y., NOMURA, D.K. & CASIDA, J.E. (2002). Selective inhibitors of fatty acid amide hydrolase relative to neuropathy target esterase and acetylcholinesterase: Toxicological implications. Toxicology and Applied Pharmacology 179, 57-63.
63. RAMÓN Y CAJAL, S. (1972) The Structure of the Retina. Translated by THORPE, S.A. & GLICKSTEIN, M., Springfield: Charles C Thomas.
64. RUSSO, E.B., MERZOUKI, A., MESA, J.M., FREY, K.A. & BACH, P.J. (2004). Cannabis improves night vision: A case study of dark adaptometry and scotopic sensitivity in kif smokers of the Rif mountains of northern Morocco. Journal of Ethnopharmacology 93, 99-104.
65. SALZET, M. & STEFANO, G.B. (2002). The endocannabinoid system in invertebrates. Prostaglandins Leukotrienes and Essential Fatty Acids 66, 353-361.
66. SCHLICKER, E. & KATHMANN, M. (2001). Modulation of transmitter release via presynaptic cannabinoid receptors. Trends in Pharmacological Science 22, 565-572.
67. SCHLICKER, E., TIMM, J. & GÖTHERT, M. (1996). Cannabinoid receptor-mediated inhibition of dopamine release in the retina. Naunyn-Schmiedebergs Archives of Pharmacology 354, 791-795.
68. SHOWALTER, V.M., COMPTON, D.R., MARTIN B.R. & ABOOD, M.E. (1996). Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): Identification of cannabinoid receptor subtype selective ligands. Journal of Pharmacology and Experimental Therapeutics 278, 989-999.
69. STAMER, W.D., GOLIGHTLY, S.F., HOSOHATA, Y., RYAN, E.P., PORTER, A.C., VARGA, E., NOECKER, R.J., FELDER, C.C. & YAMAMURA, H.I. (2001). Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues. European Journal of Pharmacology 431, 277-286.
70. STRAIKER, A., STELLA, N., PIOMELLI, D., MACKIE, K., KARTEN, H.J. & MAGUIRE, G. (1999). Cannabinoid CB1 receptors and ligands in vertebrate retina: Localization and function of an endogenous signaling system. Proceedings of the National Academy of Sciences of the U.S.A. 96, 14565-14570.
71. STRAIKER, A. & SULLIVAN, J.M. (2003). Cannabinoid receptor activation differentially modulates ion channels in photoreceptors of the tiger salamander. Journal of Neurophysiology 89, 2647-2654.
72. STREET, I.P., LIN, H.K., LALIBERTE, F., GHOMASHCHI, F., WANG, Z., PERRIER, H., TREMBLAY, N.M., HUANG, Z., WEECH, P.K. & GELB, M.H. (1993). Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2. Biochemistry 32, 5935-5940.
73. STRUIK, M., YAZULLA, S. & KAMERMANS, M. (2003). Cannabinoids modulate the cone light response in goldfish. Investigative Ophthalmology and Visual Science 44, E-Abstract 4168.
74. SUGIURA, T., KONDO, S., SUKAGAWA, A., NAKANE, S., SHINODA, A., ITOH, K., YAMASHITA, A. & WAKU, K. (1995). 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain. Biochemical and Biophysical Research Communications 215, 89-97.
75. TSOU, K., NOGUERÓN, I., MUTHIAN, S., SAÑUDO-PEÑA, M.C., HILLARD, C.J., DEUTSCH, D.G. & WALKER, J.M. (1998). Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry. Neuroscience Letters 254, 1-4.
76. UEDA, N., KURAHASHI, Y., YAMAMOTO, S. & TOKUNAGA, T. (1995). Partial purification and characterization of the porcine brain enzyme hydrolyzing and synthesizing anandamide. Journal of Biological Chemistry 270, 23823-23827.
77. VARMA, N., CARLSON, G.C., LEDENT, C. & ALGER, B.E. (2001). Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. Journal of Neuroscience 21, RC188.
78. WATANABE, K., OGI, H., NAKAMURA, S., KAYANO, Y., MATSUNAGA, T., YOSHIMURA, H. & YAMAMOTO, I. (1998). Distribution and characterization of anandamide amidohydrolase in mouse brain and liver. Life Science 62, 1223-1229.
79. WILSON, R.I. & NICOLL, R.A. (2002). Neuroscience - Endocannabinoid signaling in the brain. Science 296, 678-682.
80. YAMAMURA, H.I., ENNA, S.J. & KUHAR, M.J. (1978). Neurotransmitter Receptor Binding. New York: Raven Press.
81. YAZULLA, S., STUDHOLME, K.M., MCINTOSH, H.H. & DEUTSCH, D.G. (1999). Immunocytochemical localization of cannabinoid CB1 receptor and fatty acid amide hydrolase in rat retina. Journal of Comparative Neurology 415, 80-90.
82. YAZULLA, S., STUDHOLME, K.M., MCINTOSH, H.H. & FAN, S.F. (2000). Cannabinoid receptors on goldfish retinal bipolar cells: Electronmicroscope immunocytochemistry and whole-cell recordings. Visual Neuroscience 17, 391-401.
83. 2 ethanolamide from anandamide by cyclooxygenase-2. Journal of Biological Chemistry 272, 21181-21186.